Stay updated on Evaluating Therapeutic HSV-2 Vaccine Formulation Clinical Trial

Sign up to get notified when there's something new on the Evaluating Therapeutic HSV-2 Vaccine Formulation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Evaluating Therapeutic HSV-2 Vaccine Formulation Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Locations section now lists study sites by state (Alabama, California, Massachusetts, North Carolina, Ohio, Texas, Washington). The page revision has been updated to v3.3.3 (replacing v3.3.2).
    Difference
    0.8%
    Check dated 2025-12-24T11:33:11.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    The Publications section wording was updated to indicate that publications are automatically filled from PubMed and the Revision label changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T13:35:41.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Removed the government funding/operating-status banner from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:21:09.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The Study Details page content, sections, and data appear unchanged across screenshots; no substantive updates to the study information or navigation are visible.
    Difference
    0.4%
    Check dated 2025-11-03T21:22:36.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Significant update: new operating-status notice and version bump to v3.2.0; previous v3.1.0 tag removed. Core content impacted by the new status information.
    Difference
    4%
    Check dated 2025-10-06T05:49:27.000Z thumbnail image
  9. Check
    97 days ago
    Change Detected
    Summary
    Version bump to v3.1.0 with removal of several risk-topic sections (Drug Safety, Counterfeit Drugs, Substandard Drugs) and reorganization headers around the new revision.
    Difference
    0.4%
    Check dated 2025-09-29T03:08:29.000Z thumbnail image

Stay in the know with updates to Evaluating Therapeutic HSV-2 Vaccine Formulation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Evaluating Therapeutic HSV-2 Vaccine Formulation Clinical Trial page.